XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
G
G

Grifols


뉴스

Admiral Group, IAG, Keller Group

EUROPE RESEARCH ROUNDUP- Admiral Group, IAG, Keller Group Aug 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral Group, IAG and Keller Group, on Wednesday. HIGHLIGHTS * Admiral Group Plc ADML.L : HSBC raises target price to 2700p from 2625p * IAG ICAG.L : Citigroup raises target price to 245p from 225p * Keller Group Plc KLR.L : Deutsche Bank raises target price to 1800p from 1550p * OCI NV OCI.AS : JP Morgan raises to overw
A
A
A
B
B
B
B
G
H
I
K
L
M
R
R
S
T
V
Q
M
R

Grifols takes $494 mln writedown on Chinese investment

UPDATE 2-Grifols takes $494 mln writedown on Chinese investment Adds trading resumes in para 3, results in paragraphs 6-9 By Inti Landauro MADRID, July 30 (Reuters) - Spanish drugmaker Grifols GRLS.MC has taken a 457 million euros ($494 million) writedown on its accounts for 2020 through 2023, to reflect what it says was a previously incorrect accounting treatment of its stake in China's Shanghai RAAS 002252.SZ .
G

Grifols Reaffirms 2024 Guidance

BRIEF-Grifols Reaffirms 2024 Guidance July 30 (Reuters) - Grifols SA GRLS.MC : REAFFIRMED GUIDANCE FOR 2024 Q2 TOTAL REVENUE 1.81 BILLION EUROS Q2 ADJUSTED EBITDA 441 MILLION EUROS Q2 REPORTED EBITDA 413.6 MILLION EUROS VERSUS 339.3 MILLION EUROS YEAR AGO Q2 NET PROFIT 15 MLN EUROS Q2 R&D NEGATIVE 90.7 MLN EUROS VS NEGATIVE 88.6 MLN EUROS YR AGO So
G

Grifols Restates Comparative Figures In H1 2024 Financial Statement

BRIEF-Grifols Restates Comparative Figures In H1 2024 Financial Statement July 30 (Reuters) - Grifols SA GRLS.MC : DUE TO INCORRECT ACCOUNTING TREATMENT, COMPARATIVE FIGURES PRESENTED IN CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR H1 2024 HAVE BEEN RESTATED COMPARATIVE FIGURES FOR H1 2023 HAVE BEEN RESTATED RESULTING IN REDUCTION IN NET
G

Grifols revises past financial records with equity value drop of $494 mln

Grifols revises past financial records with equity value drop of $494 mln MADRID, July 30 (Reuters) - Spanish pharmaceutical company Grifols GRLS.MC said on Tuesday it had revised its financial records between 2020 and 2023 lower by 457 million euros ($494 million) to adjust the value of its stake in Chinese company Shanghai RAAS. Spain's stock market regulator CNMV had earlier suspended trading in Grifols shares after Bloomberg first reported the revision, citing sources, on the day Grifols is
G

Greencore, UCB, Unilever

EUROPE RESEARCH ROUNDUP-Greencore, UCB, Unilever July 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Greencore, UCB, and Unilever, on Friday. HIGHLIGHTS * Greencore GNC.L : HSBC raises target price to 190p from 160p * Lonza Group AG LONN.S : JP Morgan raises target price to CHF 645 from CHF 600 * Sartorius Stedim Biotech STDM.PA : HSBC cuts target price to EUR 310 from EUR 360 * UCB SA UCB.BR : TD Cowen raises target price to E
A
A
A
B
B
B
B
B
C
D
D
E
G
G
G
L
N
N
P
R
S
U
A
A
A
A
A
A
B
D
J

Grifols Agree Not To Proceed With Immunology Research Center With Andorran Government

BRIEF-Grifols Agree Not To Proceed With Immunology Research Center With Andorran Government July 25 (Reuters) - Grifols SA GRLS.MC : AGREE NOT TO PROCEED WITH IMMUNOLOGY RESEARCH CENTER WITH ANDORRAN GOVERNMENT DISSOLVED JOINT VENTURE WITH ANDORRA DEVELOPMENT AND INVESTMENT TO OVERSEE PROJECT Source text: https://tinyurl.com/swhrpafc Further compan
G

Spanish stocks - Factors to watch on July 22

Spanish stocks - Factors to watch on July 22 July 22 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: GRIFOLS GRLS.MC The Spanish drugmaker said on Friday it had appointed Morgan Stanley and Goldman Sachs as financial advisors for potential Brookfield's takeover bid.
A
A
G
N
M
S

Grifols Appoints Morgan Stanley And Goldman Sachs As Financial Advisors For Potential Brookfield's Takeover Bid

BRIEF-Grifols Appoints Morgan Stanley And Goldman Sachs As Financial Advisors For Potential Brookfield's Takeover Bid July 22 (Reuters) - GRIFOLS GRLS.MC : SAID ON FRIDAY IN RELATION TO ANNOUNCEMENT OF POTENTIAL TRANSACTION TO BE CARRIED OUT BY FAMILY SHAREHOLDERS AND BROOKFIELD THAT IT APPOINTS AND RETAINS MORGAN STANLEY AND GOLDMAN SACHS AS FINAN
G

Spanish stocks - Factors to watch on July 17

Spanish stocks - Factors to watch on July 17 July 17 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: GRIFOLS GRLS.MC Spanish drugmaker Grifols said on Tuesday it appointed Montserrat Munoz Abellana as the new lead independent board member.
G
T
M
S

Grifols' Board Names Montserrat Munoz Abellana As New Lead Independent Director

BRIEF-Grifols' Board Names Montserrat Munoz Abellana As New Lead Independent Director July 16 (Reuters) - Grifols SA GRLS.MC : APPOINTS MONTSERRAT MUNOZ ABELLANA AS NEW LEAD INDEPENDENT DIRECTOR OF COMPANY'S BOARD Source text for Eikon: ID:nCNMb01Wpz Further company coverage: GRLS.MC (Gdansk Newsroom)
G

Grifols falls after Moody's withdraws CEF, PDR ratings

REFILE-BUZZ-Grifols falls after Moody's withdraws CEF, PDR ratings Adds comment from a company source in bullet 3 refiles to adjust source description in advisory with no change to body text ** Shares in Grifols GRLS.MC fall 4.6% after Moody's said on Friday it had withdrawn its B3 corporate family rating and B3-PD probability of default rating on
G
S

Grifols falls after Moody's withdraws CEF, PDR ratings

BUZZ-Grifols falls after Moody's withdraws CEF, PDR ratings ** Shares in Grifols GRLS.MC fall 4.7% after Moody's said on Friday it had withdrawn its B3 corporate family rating and B3-PD probability of default rating on the Spanish drugmaker ** In its report, the rating agency said it had "insufficient or otherwise inadequate" information to support
G
S

Grifols Informs On Committee Of Board Of Directors

BRIEF-Grifols Informs On Committee Of Board Of Directors July 12 (Reuters) - Grifols GRLS.MC : IN RELATION TO POSSIBLE TRANSACTION WITH BROOKFIELD, TO SET UP COMMITTEE OF BOARD OF DIRECTORS COMPOSED EXCLUSIVELY OF INDEPENDENT DIRECTORS TO APPOINT AND HIRE LATHAM & WATKINS LLP AS LEGAL ADVISORS FOR NON-CONFLICTED DIRECTORS AND TRANSACTION COMMITTEE
G

French stocks drag European shares lower on political concerns

UPDATE 2-French stocks drag European shares lower on political concerns For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 down 0.9% Indivior declines on lower profit forecast BP slides after Q2 warning erases stock's gains in 2024 Dassault Systemes falls after guidance cut Updated at 1615 GMT By Shubham Batra and Shristi Achar A July 9 (Reuters) - European shares dropped for a third straight session on Tuesday, dragged down by we
D
G
E
F
U
G

Busy beginning in Britain

LIVE MARKETS-Busy beginning in Britain Stoxx 600 down 0.2%, U.S. futures up around 0.2% CAC 40 0.6% lower election still in focus Indivior down 38%, Stoxx 600 biggest faller Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com BUSY BEGINNING IN BRITAIN European shares are a touch lower in the first hour of trading, but the news flow is at the single-stock rather than index level.
A
E
G
P
R
R
E
F
U
G

Profit warnings and take-privates

LIVE MARKETS-Profit warnings and take-privates Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com PROFIT WARNINGS AND TAKE PRIVATES For the first time in a few days, there is no major political news for European stocks to digest. The big picture story is back to being about the U.S.
E
G
P
R
E
F
G

Grifols says founding family, Brookfield looking to delist drugmaker

RPT-UPDATE 3-Grifols says founding family, Brookfield looking to delist drugmaker Repeats story first published on Monday By Andres Gonzalez, David Latona, Joan Faus LONDON/MADRID/BARCELONA, July 8 (Reuters) - The Grifols family and Canadian fund Brookfield BN.TO have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols GRLS.MC with the intent to delist it, the companies said in regulatory filings on Monday.
G
S

Grifols says founding family, Brookfield looking to delist drugmaker

RPT-UPDATE 3-Grifols says founding family, Brookfield looking to delist drugmaker Repeats story first published on Monday By Andres Gonzalez, David Latona, Joan Faus LONDON/MADRID/BARCELONA, July 8 (Reuters) - The Grifols family and Canadian fund Brookfield BN.TO have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols GRLS.MC with the intent to delist it, the companies said in regulatory filings on Monday.
G
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Petrobras, Envestnet, Metro Bank; Updates Eli Lilly, Masimo July 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1 945 GMT on Monday: * * Brazilian logistics firm Transpetro, a unit of state-run oil firm Petrobras PETR4.SA , said it has launched a procurement notice to commission four new coastal vessels, which it hopes will help revive the nation's shipbuilding sector.
B
G
T



조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.